Feed TTOO
TT

T2 Biosystems, Inc.

TTOO · OTC

$0.00 +0.00% (+$0.00)
1M -80.00%
Market Cap $16.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.00x
P/FCF N/A
P/B N/A
Growth
0 /100
Declining
Rev. growth 26.52%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak
FCF margin 671.88%
Op. margin 690.45%
Gross margin 113.58%
Quality
4 /100
Poor
ROA 143.91%
Asset turnover 0.21x
ROIC 230.51%
Debt
1 /100
High
Int. coverage -8.37x
Current ratio 0.45x
Net debt/EBITDA N/A
Stability
14 /100
Unstable
Profitable years 0
EPS volatility 45.06%
Beta 7.95x

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about TTOO
Online

About the company

T2 Biosystems, Inc. is an American biotechnology company that specializes in the diagnosis of infectious diseases. It utilizes a technology called T2 Magnetic Resonance (T2MR), which combines magnetic resonance with nanoparticles for the detection of pathogens in biological samples. T2 Biosystems focuses on innovative diagnostic solutions aimed at accelerating the process of infection diagnosis and improving patient care. Shares of T2 Biosystems, Inc. are traded on the stock exchange and may be an interesting investment opportunity for those following developments in biotechnology and diagnostics.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Craig R. Jalbert

Employees

113

Headquarters

Lexington

Upcoming events

13 NOV

Earnings

Upcoming earnings report

52d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.